Plasma levels of nitric oxide related amino acids in demented subjects with Down syndrome are related to neopterin concentrations

被引：17

作者：

Coppus, A. M. W. ^{[1
,2
]}

Fekkes, D. ^{[3
,5
]}

Verhoeven, W. M. A. ^{[4
,5
]}

Tuinier, S. ^{[4
]}

van Duijn, C. M. ^{[2
]}

机构：

[1] Ctr Intellectually Disabled, Dichterbij, Gennep, Netherlands

[2] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands

[3] Erasmus Univ, Med Ctr, Dept Neurosci, Rotterdam, Netherlands

[4] Vincent van Gogh Inst Psychiat, Venray, Netherlands

[5] Erasmus Univ, Med Ctr, Dept Psychiat, Rotterdam, Netherlands

来源：

AMINO ACIDS | 2010年 / 38卷 / 03期

关键词：

Amino acids; Down syndrome; Neopterin; Nitric oxide; Branched chain amino acids; INDIVIDUALS; DIAGNOSIS;

D O I：

10.1007/s00726-009-0300-5

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Subjects with Down syndrome (DS) have abnormalities in virtually all aspects of the immune system and almost all will be affected with Alzheimer's disease (AD). It is thought that nitric oxide (NO) is involved in the pathophysiology of AD. In the present study, including a total of 401 elderly DS subjects, the spectrum of plasma amino acids and neopterin was investigated and related to development of AD. Concentrations of nearly all amino acids in DS subjects differed significantly from those of healthy controls. Neopterin was increased in DS subjects, especially in dementia. The production of NO as reflected by an increased citrulline/arginine ratio (Cit/Arg ratio) was enhanced during development of clinical dementia. Neopterin concentrations correlated to the Cit/Arg ratio only in the group of prevalent demented subjects (rho = 0.48, P = 0.006). The results of this study are suggestive for an increase in oxidative processes in DS subjects with AD.

引用

页码：923 / 928

页数：6

共 28 条

[1] Genetic association between endothelial nitric oxide synthase and Alzheimer disease [J].

Akomolafe, A. ;

Lunetta, K. L. ;

Erlich, P. M. ;

Cupples, L. A. ;

Baldwin, C. T. ;

Huyck, M. ;

Green, R. C. ;

Farrer, L. A. .

CLINICAL GENETICS, 2006, 70 (01) :49-56

[2]

Akyol O, 2004, IN VIVO, V18, P377

[3]

[Anonymous], 1992, MIEDZ KLAS CHOR PROB

[4] Diagnosis of dementia in individuals with intellectual disability [J].

Aylward, EH ;

Burt, DB ;

Thorpe, LU ;

Lai, F ;

Dalton, A .

JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 1997, 41 :152-164

[5] Hypothalamic nitric oxide synthase in affective disorder: Focus on the suprachiasmatic nucleus [J].

Bernstein, HG ;

Heinemann, A ;

Krell, D ;

Dobrowolny, H ;

Bielau, H ;

Keilhoff, G ;

Bogerts, B .

CELLULAR AND MOLECULAR BIOLOGY, 2005, 51 (03) :279-284

[6] Test battery for the diagnosis of dementia in individuals with intellectual disability [J].

Burt, DB ;

Aylward, EH .

JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2000, 44 :175-180

[7] Protein expression of BACE1, BACE2 and APP in down syndrome brains [J].

Cheon, M. S. ;

Dierssen, M. ;

Kim, S. H. ;

Lubec, G. .

AMINO ACIDS, 2008, 35 (02) :339-343

[8] Dementia and mortality in persons with Down's syndrome [J].

Coppus, A. ;

Evenhuis, H. ;

Verberne, G. -J. ;

Visser, F. ;

van Gool, P. ;

Eikelenboom, P. ;

van Duijin, C. .

JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2006, 50 :768-777

[9] Plasma amino acids and neopterin in healthy persons with Down's syndrome [J].

Coppus, A. W. ;

Fekkes, D. ;

Verhoeven, W. M. A. ;

Tuinier, S. ;

Egger, J. I. M. ;

van Duijn, C. M. .

JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (08) :1041-1045

[10]

COPPUS AM, 2009, NEOPTERIN RISK DEMEN, DOI DOI 10.1016/J.NEULET.2009.04.020

← 1 2 3 →